反应条件
1.1: potassium phosphate; potassium acetate; triphenylphosphine; [Ru(II)(η6-benzene)(μ-Cl)Cl]2 / 1-methyl-pyrrolidin-2-one / 42 h / 110 - 130 °C / |Inert atmosphere 2.1: N-ethyl-N,N-diisopropylamine; methyl chloroformate / tetrahydrofuran / 0.75 h / 62 °C 2.2: 13 h / 0 - 20 °C 3.1: thionyl chloride / N,N-dimethyl-formamide / 5 h / 10 - 20 °C 4.1: sodium hexamethyldisilazane / N,N-dimethyl-formamide / -15 - 12 °C View Scheme
参考文献
LEK PHARMACEUTICALS D.D.; HUMLJAN, Jan; MARAS, Nenad
Patent: WO2013/91696 A1, 2013 ;